Enanta Pharmaceuticals Stock Today
| ENTA Stock | USD 13.32 0.09 0.68% |
Performance5 of 100
| Odds Of DistressLess than 11
|
Enanta Pharmaceuticals is trading at 13.32 as of the 19th of April 2024, a 0.68 percent increase since the beginning of the trading day. The stock's open price was 13.23. Enanta Pharmaceuticals has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Enanta Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of April 2022 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 21st of March 2013 | Category Healthcare | Classification Health Care |
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts. The company has 21.16 M outstanding shares of which 2.74 M shares are currently shorted by private and institutional investors with about 10.82 trading days to cover. More on Enanta Pharmaceuticals
Follow Valuation Options Odds of Bankruptcy
Financial Report 13th of May 2024
Enanta Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Enanta Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Enanta Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Jay Luly | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Trump Equities (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Trump Equities, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Enanta Pharmaceuticals report their recommendations after researching Enanta Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Enanta Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Enanta Pharmaceuticals. The Enanta consensus assessment is calculated by taking the average forecast from all of the analysts covering Enanta Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Enanta Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Enanta Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Enanta Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enanta Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Enanta Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Enanta Pharmaceuticals' financial leverage. It provides some insight into what part of Enanta Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Enanta Pharmaceuticals (ENTA) is traded on NASDAQ Exchange in USA. It is located in 500 Arsenal Street, Watertown, MA, United States, 02472 and employs 145 people. Enanta Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 279.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Enanta Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Enanta Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Enanta Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 21.16 M outstanding shares of which 2.74 M shares are currently shorted by private and institutional investors with about 10.82 trading days to cover.
Enanta Pharmaceuticals currently holds about 253.29 M in cash with (103.15 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.22.
Check Enanta Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationEnanta Pharmaceuticals retains a total of 21.16 Million outstanding shares. The majority of Enanta Pharmaceuticals outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Enanta Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Enanta Pharmaceuticals. Please pay attention to any change in the institutional holdings of Enanta Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Enanta Ownership Details
Enanta Stock Price Odds Analysis
What are Enanta Pharmaceuticals' target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Enanta Pharmaceuticals jumping above the current price in 90 days from now is about 66.65%. The Enanta Pharmaceuticals probability density function shows the probability of Enanta Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.9305 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Enanta Pharmaceuticals will likely underperform. Additionally, enanta Pharmaceuticals has an alpha of 0.1887, implying that it can generate a 0.19 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Enanta Pharmaceuticals to move above the current price in 90 days from now is about 66.65 (This Enanta Pharmaceuticals probability density function shows the probability of Enanta Stock to fall within a particular range of prices over 90 days) .
Enanta Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Enanta Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Enanta Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Enanta Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Renaissance Technologies Corp | 2023-12-31 | 558.5 K | |
| Geode Capital Management, Llc | 2023-12-31 | 429.2 K | |
| State Street Corporation | 2023-12-31 | 425.6 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 373.3 K | |
| D. E. Shaw & Co Lp | 2023-09-30 | 361.1 K | |
| Jacobs Levy Equity Management, Inc. | 2023-09-30 | 345.7 K | |
| Two Sigma Investments Llc | 2023-12-31 | 332.2 K | |
| Two Sigma Advisers, Llc | 2023-12-31 | 290.8 K | |
| Ubs Asset Mgmt Americas Inc | 2023-12-31 | 224.1 K | |
| Armistice Capital, Llc | 2023-12-31 | 2.1 M | |
| Farallon Capital Management, L.l.c. | 2023-12-31 | 2 M |
Enanta Pharmaceuticals Historical Income Statement
Enanta Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Enanta's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Enanta Pharmaceuticals revenue and expense. Enanta Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Enanta Pharmaceuticals' Selling General Administrative is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 104.9 M, whereas Depreciation And Amortization is forecasted to decline to about 1.9 M. View More FundamentalsEnanta Stock Against Markets
Picking the right benchmark for Enanta Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Enanta Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Enanta Pharmaceuticals is critical whether you are bullish or bearish towards Enanta Pharmaceuticals at a given time. Please also check how Enanta Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Enanta Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Enanta Pharmaceuticals Corporate Directors
Enanta Pharmaceuticals corporate directors refer to members of an Enanta Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Enanta Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Enanta Pharmaceuticals' board members must vote for the resolution. The Enanta Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Carol Miceli | Director, Investor Relations | Profile | |
| Kristine Peterson | Director | Profile | |
| ErnstGunter Afting | Independent Director | Profile | |
| Stephen Buckley | Independent Director | Profile |
How to buy Enanta Stock?
Before investing in Enanta Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Enanta Pharmaceuticals. To buy Enanta Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Enanta Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Enanta Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Enanta Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Enanta Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Enanta Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Enanta Stock please use our How to Invest in Enanta Pharmaceuticals guide.
Already Invested in Enanta Pharmaceuticals?
The danger of trading Enanta Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Enanta Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Enanta Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Enanta Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Enanta Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Enanta Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Enanta Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Enanta Pharmaceuticals Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enanta Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Enanta Stock refer to our How to Trade Enanta Stock guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for Enanta Stock analysis
When running Enanta Pharmaceuticals' price analysis, check to measure Enanta Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enanta Pharmaceuticals is operating at the current time. Most of Enanta Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Enanta Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enanta Pharmaceuticals' price. Additionally, you may evaluate how the addition of Enanta Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Enanta Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Enanta Pharmaceuticals. If investors know Enanta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Enanta Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (6.57) | Revenue Per Share 3.5 | Quarterly Revenue Growth (0.24) | Return On Assets (0.23) |
The market value of Enanta Pharmaceuticals is measured differently than its book value, which is the value of Enanta that is recorded on the company's balance sheet. Investors also form their own opinion of Enanta Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Enanta Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Enanta Pharmaceuticals' market value can be influenced by many factors that don't directly affect Enanta Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Enanta Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enanta Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enanta Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.